These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32584463)

  • 1. Profiles of cognitive impairment in the continuum from normal cognition to Alzheimer's clinical syndrome: Contributions of the short-term memory binding tests.
    Cecchini MA; Foss MP; Tumas V; Patrocinio FAP; Chiari-Correia RD; Novaretti N; Brozinga TR; Bahia VS; de Souza LC; Cerqueira Guimarães H; Caramelli P; Lima-Silva TB; Cassimiro L; Brucki SMD; Nitrini R; Della Sala S; Parra MA; Yassuda MS
    Int J Geriatr Psychiatry; 2020 Nov; 35(11):1331-1340. PubMed ID: 32584463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficits in short-term memory binding are detectable in individuals with brain amyloid deposition in the absence of overt neurodegeneration in the Alzheimer's disease continuum.
    Cecchini MA; Yassuda MS; Squarzoni P; Coutinho AM; de Paula Faria D; Duran FLS; Costa NAD; Porto FHG; Nitrini R; Forlenza OV; Brucki SMD; Buchpiguel CA; Parra MA; Busatto GF
    Brain Cogn; 2021 Aug; 152():105749. PubMed ID: 34022637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recalling feature bindings differentiates Alzheimer's disease from frontotemporal dementia.
    Cecchini MA; Yassuda MS; Bahia VS; de Souza LC; Guimarães HC; Caramelli P; Carthery-Goulart MT; Patrocínio F; Foss MP; Tumas V; Lima-Silva TB; Brucki SMD; Nitrini R; Della Sala S; Parra MA
    J Neurol; 2017 Oct; 264(10):2162-2169. PubMed ID: 28894929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early diagnosis of mild cognitive impairment and Alzheimer's with event-related potentials and event-related desynchronization in N-back working memory tasks.
    Fraga FJ; Mamani GQ; Johns E; Tavares G; Falk TH; Phillips NA
    Comput Methods Programs Biomed; 2018 Oct; 164():1-13. PubMed ID: 30195417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term delayed recall of auditory verbal learning test provides equivalent value to long-term delayed recall in predicting MCI clinical outcomes: A longitudinal follow-up study.
    Xu Y; Chen K; Zhao Q; Li F; Guo Q
    Appl Neuropsychol Adult; 2020; 27(1):73-81. PubMed ID: 30470140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of memory fMRI response among normal, MCI, and Alzheimer's patients.
    Machulda MM; Ward HA; Borowski B; Gunter JL; Cha RH; O'Brien PC; Petersen RC; Boeve BF; Knopman D; Tang-Wai DF; Ivnik RJ; Smith GE; Tangalos EG; Jack CR
    Neurology; 2003 Aug; 61(4):500-6. PubMed ID: 12939424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-domain Cognitive Testing: A Biomarker for Classifying the Cognitive Status of Mild Cognitive Impairment and Alzheimer's Disease.
    Kumar Gurja JP; Muthukrishnan SP; Tripathi M; Mehta N; Sharma R
    Neurol India; 2022; 70(3):1057-1063. PubMed ID: 35864639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease?
    Cecato JF; Martinelli JE; Izbicki R; Yassuda MS; Aprahamian I
    Int Psychogeriatr; 2016 May; 28(5):825-32. PubMed ID: 26620850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of cognitive decline in Alzheimer's disease and mild cognitive impairment using the CAMCOG: a five-year follow-up.
    Conde-Sala JL; Garre-Olmo J; Vilalta-Franch J; Llinàs-Reglà J; Turró-Garriga O; Lozano-Gallego M; Hernández-Ferrándiz M; Pericot-Nierga I; López-Pousa S
    Int Psychogeriatr; 2012 Jun; 24(6):948-58. PubMed ID: 22278151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Free Recall of Bound Information Held in Short-Term Memory is Unimpaired by Age and Education.
    Yassuda MS; Carthery-Goulart MT; Cecchini MA; Cassimiro L; Fernandes KD; Baradel RR; Garcia RB; Nitrini R; Della Sala S; Parra MA
    Arch Clin Neuropsychol; 2020 Feb; 35(2):165-175. PubMed ID: 30994913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic receptor binding in unimpaired older adults, mild cognitive impairment, and Alzheimer's disease dementia.
    Sultzer DL; Lim AC; Gordon HL; Yarns BC; Melrose RJ
    Alzheimers Res Ther; 2022 Feb; 14(1):25. PubMed ID: 35130968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.